Evaluation of erythropoietin effects on cerebral ischemia in rats
- PMID: 17435667
Evaluation of erythropoietin effects on cerebral ischemia in rats
Abstract
Objective: Majority of severe disabilities in adults are caused by stroke. The aim of our study is to learn the effects of erythropoietin (EPO), on infarct size in cerebral ischemia and to determine neurological behavioral scores and histopathological evaluation.
Material & methods: In this study 30 adult Sprague-Dawney rats were used. Cerebral ischemia was constituted by intraluminal filament method with a 4-0-nylon suture. Reperfusion was started after two hours of middle cerebral artery occlusion. The rats were randomly divided into two groups as follow: control and EPO groups. Saline 0.9% (0.5 ml/kg) and EPO (5 000 U/kg) was administered intraperitoneally in the groups. Three coronal slices in two millimeters thickness were obtained from cerebrum, cerebellum and brain stem, and were stained with a 2% solution of triphenyltetrazolium chloride. Transparent sheets were placed over each section and the areas of the brain and infarct were measured. The neurological scores were determined at 24th, 48th and 72nd hours after reperfusion.
Results: Percent of ischemic area (%) in cerebrum, cerebellum and brain stem level in EPO groups were less than those of control group (p<0.0001). In addition, we determined that EPO group was better than controls of neurologic score and histopathologically after cerebral ischemia.
Conclusions: We concluded that EPO may decrease ischemic area in experimental cerebral ischemia in rats and it seems that EPO may be beneficial.
Similar articles
-
Evaluation of effects of memantine on cerebral ischemia in rats.Neurosciences (Riyadh). 2008 Apr;13(2):113-6. Neurosciences (Riyadh). 2008. PMID: 21063302
-
Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.Neurosci Lett. 2005 Oct 14;387(1):5-10. doi: 10.1016/j.neulet.2005.07.008. Neurosci Lett. 2005. PMID: 16054296
-
Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.Ann Emerg Med. 2006 Apr;47(4):381-9. doi: 10.1016/j.annemergmed.2005.12.011. Epub 2006 Feb 21. Ann Emerg Med. 2006. PMID: 16546625
-
[Erythropoietin--a new therapy in cerebral ischemia?].Ugeskr Laeger. 2003 Jun 9;165(24):2477-81. Ugeskr Laeger. 2003. PMID: 12872467 Review. Danish.
-
Erythropoietin in stroke: quo vadis.Expert Opin Biol Ther. 2010 Jun;10(6):937-49. doi: 10.1517/14712598.2010.481435. Expert Opin Biol Ther. 2010. PMID: 20394473 Review.
Cited by
-
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment.Pharmaceuticals (Basel). 2023 Apr 18;16(4):610. doi: 10.3390/ph16040610. Pharmaceuticals (Basel). 2023. PMID: 37111367 Free PMC article. Review.
-
Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats.Clin Exp Nephrol. 2014 Dec;18(6):855-64. doi: 10.1007/s10157-014-0937-6. Epub 2014 Feb 4. Clin Exp Nephrol. 2014. PMID: 24493464
-
Combination antioxidant effect of erythropoietin and melatonin on renal ischemia-reperfusion injury in rats.Iran J Basic Med Sci. 2013 Dec;16(12):1209-16. Iran J Basic Med Sci. 2013. PMID: 24570825 Free PMC article.
-
A systematic review and meta-analysis of erythropoietin in experimental stroke.J Cereb Blood Flow Metab. 2010 May;30(5):961-8. doi: 10.1038/jcbfm.2009.267. Epub 2009 Dec 30. J Cereb Blood Flow Metab. 2010. PMID: 20040929 Free PMC article.
-
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):1-43. doi: 10.1007/s00210-007-0183-5. Epub 2007 Sep 22. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 18038125 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials